A pulmonologist has raised concerns about a wave of new wellness claims being made about nicotine, according to a guest column published by The Washington Post on Sunday, September 20, 2026. The physician, writing in the paper's opinion pages, said the marketing of nicotine as a wellness product is worrying from a lung health perspective.
The column's headline frames the piece as a direct warning from a lung specialist. The Washington Post reports that the author's concern centers on how nicotine is being positioned in wellness messaging, rather than on any single product or study.
The piece arrives amid broader public debate over how nicotine products are marketed and perceived. The Washington Post published the column as a guest contribution, meaning the views belong to the physician rather than the newspaper's editorial board. No specific products, companies, or research findings were named in the headline and summary available.
Because the column is an opinion piece, it reflects the author's professional perspective as a pulmonologist rather than new clinical data. The Washington Post has not indicated whether a response or follow-up is planned.
Watch for further coverage of nicotine marketing claims and any public health or regulatory response they draw.
